1. Home
  2. BTE vs TWST Comparison

BTE vs TWST Comparison

Compare BTE & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baytex Energy Corp

BTE

Baytex Energy Corp

HOLD

Current Price

$4.13

Market Cap

3.0B

ML Signal

HOLD

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$47.96

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTE
TWST
Founded
1993
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
BTE
TWST
Price
$4.13
$47.96
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$46.25
AVG Volume (30 Days)
24.9M
1.0M
Earning Date
05-04-2026
05-04-2026
Dividend Yield
1.62%
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
N/A
$376,572,000.00
Revenue This Year
N/A
$18.91
Revenue Next Year
$7.93
$15.07
P/E Ratio
$18.43
N/A
Revenue Growth
N/A
20.32
52 Week Low
$1.44
$23.30
52 Week High
$4.56
$57.88

Technical Indicators

Market Signals
Indicator
BTE
TWST
Relative Strength Index (RSI) 51.18 50.54
Support Level $3.90 $41.85
Resistance Level $4.56 $57.88
Average True Range (ATR) 0.19 2.84
MACD -0.04 0.25
Stochastic Oscillator 37.52 43.44

Price Performance

Historical Comparison
BTE
TWST

About BTE Baytex Energy Corp

Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: